June 27, 2012
Takeda Pharmaceutical and Massachusetts-based AMAG Pharmaceuticals Inc. on June 25 announced that Takeda’s UK subsidiary Takeda Global Research & Development Centre (Europe) Ltd. received as of June 15 marketing approval for the iron deficiency anemia treatment Rienso (ferumoxytol), for which AMAG...read more